Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 8/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 3/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 3/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | CXCR2 | P25025 | 1/20 | 0.36 |
| ▸ | PKM | P14618 | 2/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | GPR35 | Q9HC97 | 3/20 | 0.35 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7827793 | 0.89 | JAK1 (0.45) | MAPTGAALMNAALDH1A1NPSR1 | |
| SCHEMBL7815986 | 0.89 | MAPT (0.39) | MAPTLMNAALDH1A1NPSR1TP53 | |
| SCHEMBL7826306 | 0.87 | GAA (0.45) | MAPTGAALMNAALDH1A1NPSR1 | |
| SCHEMBL7816589 | 0.87 | MAPT (0.44) | MAPTGAALMNAALDH1A1NPSR1 | |
| SCHEMBL7816264 | 0.84 | TYK2 (0.47) | MAPTGAALMNAALDH1A1NPSR1 | |
| SCHEMBL7827125 | 0.83 | MAPT (0.43) | MAPTGAALMNAALDH1A1NPSR1 | |
| SCHEMBL8341717 | 0.83 | GPR35 (0.44) | MAPTGAALMNAALDH1A1NPSR1 | |
| SCHEMBL7831900 | 0.81 | MAPT (0.40) | MAPTGAALMNAALDH1A1NPSR1 | |
| SCHEMBL7831814 | 0.78 | RAB9A (0.42) | MAPTLMNAALDH1A1NPSR1TP53 | |
| SCHEMBL7829562 | 0.77 | MAPT (0.47) | MAPTLMNAALDH1A1NPSR1NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5858995-A | ADMINISTERING TO HUMANS AND ANIMALS IN THE TREATMENT OF DISEASES CAUSED BY ABNORMAL BONE METABOLISM | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1999-01-12 | — | — | US | disclosed |
| EP-0757682-A1 | BENZOFURAN DERIVATIVES USEFUL AS INHIBITORS OF BONE RESORPTION | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1997-02-12 | — | — | EP | disclosed |
| WO-1995029907-A1 | BENZOFURAN DERIVATIVES USEFUL AS INHIBITORS OF BONE RESORPTION | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1995-11-09 | — | — | WO | disclosed |